19-35030780-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The ENST00000262631.11(SCN1B):c.-41C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 857,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000020 ( 0 hom. )
Consequence
SCN1B
ENST00000262631.11 5_prime_UTR
ENST00000262631.11 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.275
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 19-35030780-C-G is Benign according to our data. Variant chr19-35030780-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 513312.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN1B | NM_001037.5 | c.-41C>G | 5_prime_UTR_variant | 1/6 | ENST00000262631.11 | NP_001028.1 | ||
SCN1B | NM_199037.5 | c.-41C>G | 5_prime_UTR_variant | 1/3 | NP_950238.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1B | ENST00000262631.11 | c.-41C>G | 5_prime_UTR_variant | 1/6 | 1 | NM_001037.5 | ENSP00000262631 | P1 | ||
SCN1B | ENST00000415950.5 | c.-41C>G | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000396915 | ||||
SCN1B | ENST00000638536.1 | c.-41C>G | 5_prime_UTR_variant | 1/5 | 1 | ENSP00000492022 | P1 | |||
SCN1B | ENST00000595652.5 | c.-41C>G | 5_prime_UTR_variant | 1/6 | 2 | ENSP00000468848 |
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149254Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
149254
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000198 AC: 14AN: 708550Hom.: 0 Cov.: 9 AF XY: 0.00000555 AC XY: 2AN XY: 360498
GnomAD4 exome
AF:
AC:
14
AN:
708550
Hom.:
Cov.:
9
AF XY:
AC XY:
2
AN XY:
360498
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000670 AC: 1AN: 149254Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72742
GnomAD4 genome
AF:
AC:
1
AN:
149254
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
72742
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at